Frank J Carroll

Title: **Frank J. Carroll: Innovator in Biogenic Amine Transporter Inhibitors**

Introduction

Frank J. Carroll, an accomplished inventor based in Durham, North Carolina, has made significant contributions to the field of pharmacology. With one patented invention to his name, Carroll's work has the potential to impact treatments for diseases characterized by dopamine deficiency.

Latest Patents

Carroll holds a patent titled "Selective Inhibitors of Biogenic Amine Transporters." This patent details a compound with a specific structural formula that includes variations of elements such as hydrogen, halogens, alkyl groups, and detailed functional groups. The invention also encompasses a pharmaceutical composition comprised of this compound along with a pharmaceutically acceptable carrier. Additionally, it outlines a method for treating diseases related to dopamine deficiencies by administering the described pharmaceutical composition.

Career Highlights

Throughout his career, Frank J. Carroll has been associated with the United States of America as represented by the Department of Health and Office of Technology Transfer. His work with this organization underscores the importance of his research in advancing healthcare solutions and therapeutic methods.

Collaborations

Carroll has collaborated with notable professionals in his field, including Richard B. Rothman and Bruce Edward Blough. Such collaborations have enriched his research endeavors and contributed to the development of innovative pharmaceutical solutions.

Conclusion

Frank J. Carroll is a prominent figure in the realm of pharmaceutical innovation. His patent on selective inhibitors of biogenic amine transporters highlights the vital role inventors like him play in addressing critical health challenges. Through his career and collaborative efforts, Carroll has made strides in creating potential treatments that could improve the lives of many individuals suffering from dopamine-related disorders.